ArticleAlimentary pharmacology & therapeutics2022

Letter: immunogenicity is not the root cause for loss of response to anti-TNF agents in patients with IBD in TDM era.

Dahham Alsoud et al.PubMed ↗Publisher ↗

No numbers read from the abstract.